Transcept Pharmaceuticals Inc (TSPT)

[surf1944]

TSPT will more than likely trade around it cash levels in the coming months & will be flat lined for now. This is another example of why you should almost always sell your bio tech position into a FDA review, most money is made into the run up to the meeting.

Total Cash (mrq): 63.29M
Total Cash Per Share (mrq): 4.70
Total Debt (mrq): 585.00K
Total Debt/Equity (mrq): 0.93
Current Ratio (mrq): 10.30
Book Value Per Share (mrq): 4.64